Business Overview
Pharmaceutical Resource Technology, Inc. (“PRT”) is a U.S. public company with a diversified operating platform in Southeast Asia. The Company’s activities span three complementary business segments:
Honey Straw Manufacturing
Pharmaceutical & Dietary Supplement Manufacturing
Building & Construction Services
PRT has developed from its earlier development stage into an established, revenue-generating business platform. The Company generated approximately US$10.82 million in consolidated revenue in FY2025, compared with approximately US$10.07 million in FY2024.
For the six months ended June 30, 2026, PRT generated approximately US$5.64 million in revenue, US$2.51 million in gross profit and US$1.09 million in operating cash flow.
Expansion Opportunity
PRT is entering an important expansion phase, with a particular focus on developing its Honey Straw manufacturing business in Thailand and expanding manufacturing capacity and distribution opportunities across Thailand and the broader Southeast Asian market.
The Honey Straw business is intended to provide a platform for expansion into the health, wellness and consumer-products sectors while complementing PRT’s existing pharmaceutical and dietary supplement manufacturing capabilities.
The Company also intends to increase manufacturing capacity, strengthen working capital, develop new products and markets, and pursue strategic business opportunities.
Strategic Investment Opportunity
PRT is open to discussions with strategic investors, business groups and qualified parties interested in participating in the Company's growth and expansion.
Potential opportunities may include:
Strategic investment
Significant equity participation
Strategic partnership
Expansion capital
Corporate or business combination opportunities
PRT is a public company and is currently pursuing a registered primary equity offering of up to 100,000,000 shares at US$0.50 per share, with target gross proceeds of US$50 million.
Any investment in PRT securities would be subject to the Company's applicable offering documents and securities laws.
Why PRT
PRT offers a combination of:
An established revenue-generating operating platform
Three complementary business segments
A U.S. public-company structure
Existing manufacturing capabilities
Identified expansion opportunities in Southeast Asia
A significant opportunity to increase manufacturing capacity and market distribution
A broader capital strategy combining growth investment with expansion initiatives
Opportunity for Strategic Buyers and Investors
This opportunity may be particularly relevant to parties seeking exposure to an operating platform with existing revenues and identified opportunities for expansion across manufacturing, health and wellness, consumer products and infrastructure-related services.
PRT is interested in speaking with serious strategic parties who can contribute capital, distribution, manufacturing capabilities, strategic relationships or other resources to accelerate the Company's development.
Enquiries
Qualified parties interested in exploring a strategic investment, partnership or other corporate opportunity are invited to make an initial enquiry.
Additional corporate, financial and offering information can be provided to qualified and interested parties following an initial discussion.
